ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
Checkpoint Therapeutics Inc

Checkpoint Therapeutics Inc (CKPT)

3.31
-0.15
(-4.34%)
마감 17 2월 6:00AM
3.35
0.04
(1.21%)
시간외 거래: 8:55AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
3.35
매수가
3.30
매도가
3.35
거래량
732,921
3.21 일간 변동폭 3.39
1.38 52주 범위 4.50
market_cap
전일 종가
3.46
개장가
3.37
최근 거래 시간
3
@
3.31
마지막 거래 시간
재정 규모
US$ 2,404,274
VWAP
3.2804
평균 볼륨(3m)
1,418,995
발행 주식
48,832,500
배당수익률
-
주가수익률
-3.12
주당순이익(EPS)
-1.06
매출
103k
순이익
-51.85M

Checkpoint Therapeutics Inc 정보

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the US. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodie... Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the US. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR related protein (GITR) and carbonic anhydrase IX (CAIX). It emphasizes on developing novel immuno-oncology and checkpoint inhibitor antibodies as well as oral targeted anti-cancer therapies consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and extra-terminal (BET) protein, BRD4, and an inhibitor of poly (ADP-ribose) polymerase (PARP). 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Dover, Delaware, USA
설립됨
-
Checkpoint Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker CKPT. The last closing price for Checkpoint Therapeutics was US$3.46. Over the last year, Checkpoint Therapeutics shares have traded in a share price range of US$ 1.38 to US$ 4.50.

Checkpoint Therapeutics currently has 48,832,500 shares in issue. The market capitalisation of Checkpoint Therapeutics is US$168.96 million. Checkpoint Therapeutics has a price to earnings ratio (PE ratio) of -3.12.

CKPT 최신 뉴스

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.16-4.55840455843.513.563.027414263.27795787CS
4003.353.862.688691423.15361578CS
12-0.14-4.011461318053.494.52.6814189953.51539275CS
261.1250.22421524662.234.52.069768653.34426559CS
521.3870.05076142131.974.51.386924542.96129446CS
156-18.35-84.562211981621.721.91.35300535.74853467CS
260-19.35-85.242290748922.753.7621.370914818.93768392CS

CKPT - Frequently Asked Questions (FAQ)

What is the current Checkpoint Therapeutics share price?
The current share price of Checkpoint Therapeutics is US$ 3.35
How many Checkpoint Therapeutics shares are in issue?
Checkpoint Therapeutics has 48,832,500 shares in issue
What is the market cap of Checkpoint Therapeutics?
The market capitalisation of Checkpoint Therapeutics is USD 168.96M
What is the 1 year trading range for Checkpoint Therapeutics share price?
Checkpoint Therapeutics has traded in the range of US$ 1.38 to US$ 4.50 during the past year
What is the PE ratio of Checkpoint Therapeutics?
The price to earnings ratio of Checkpoint Therapeutics is -3.12
What is the cash to sales ratio of Checkpoint Therapeutics?
The cash to sales ratio of Checkpoint Therapeutics is 1.58k
What is the reporting currency for Checkpoint Therapeutics?
Checkpoint Therapeutics reports financial results in USD
What is the latest annual turnover for Checkpoint Therapeutics?
The latest annual turnover of Checkpoint Therapeutics is USD 103k
What is the latest annual profit for Checkpoint Therapeutics?
The latest annual profit of Checkpoint Therapeutics is USD -51.85M
What is the registered address of Checkpoint Therapeutics?
The registered address for Checkpoint Therapeutics is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901
What is the Checkpoint Therapeutics website address?
The website address for Checkpoint Therapeutics is www.checkpointtx.com
Which industry sector does Checkpoint Therapeutics operate in?
Checkpoint Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
JTAIJet AI Inc
US$ 6.02
(133.33%)
104.48M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
254.39M
WRDWeRide Inc
US$ 31.4877
(83.39%)
21.07M
INLFINLIF Limited
US$ 16.27
(80.58%)
7.68M
MBRXMoleculin Biotech Inc
US$ 2.1201
(66.94%)
136.66M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3.08
(-56.31%)
430.77k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3.36
(-52.68%)
5.21k
CSAICloudastructure Inc
US$ 19.0001
(-49.58%)
1.03M
NEXNNexxen International Ltd
US$ 10.30
(-49.16%)
164.82k
BSLKBolt Projects Holdings Inc
US$ 0.6626
(-46.13%)
13.4M
CNSPCNS Pharmaceuticals Inc
US$ 0.1415
(31.26%)
489.28M
MGOLMGO Global Inc
US$ 0.7176
(-15.08%)
417.31M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
254.39M
INTCIntel Corporation
US$ 23.60
(-2.20%)
230.26M
NVDANVIDIA Corporation
US$ 138.85
(2.63%)
194.99M

CKPT Discussion

게시물 보기
georgie18 georgie18 2 주 전
CKPT...$3.86...Off my $3.17 Alert...🥳

georgie18

Member Level
Re: georgie18 post# 673374

Wednesday, February 05, 2025 3:21:32 PM

Post#
673461
of 673502
CKPT...$3.71...Off my $3.17...🥳... PLEASE PAY CLOSE ATTENTION TO THE CHART... https://schrts.co/TCItqZvc ...There is a long term Cup forming here which will take a year or so if it completes...for a 10X to 12X return...Short term CKPT...needs to Break/Hold $4 if so we see $8 range... https://finance.yahoo.com/news/fda-approves-checkpoint-therapeutics-skin-142201452.html

georgie18

Member Level
Re: georgie18 post# 673246

Wednesday, February 05, 2025 10:18:46 AM

Post#
673374
of 673461
CKPT...$3.50...🥳...Off my $3.17 Alert...

georgie18

Member Level
Re: georgie18 post# 673236

Tuesday, February 04, 2025 11:03:23 AM

Post#
673246
of 673372
CKPT...$3.42...HOD off my $3.17 Alert...🥳

georgie18

Member Level
Re: georgie18 post# 31459

Tuesday, February 04, 2025 10:08:02 AM

Post#
31479
of 31487
CKPT...$3.29...Bullish Psar Flip...🥳

georgie18

Member Level
Re: None

Monday, February 03, 2025 8:01:35 PM

Post#
673187
of 673235
CKPT...$3.17... 🥳... https://schrts.co/DJzbwPTt ...Closed above the 20MA with a strong Candle...40 Million Range Float...
👍️0
georgie18 georgie18 2 주 전
CKPT...$3.71...🥳... PLEASE PAY CLOSE ATTENTION TO THE CHART... https://schrts.co/TCItqZvc ...There is a long term Cup forming here which will take a year or so if it completes...for a 10X to 12X return...Short term CKPT...needs to Break/Hold $4 if so we see $8 range...
👍️0
vein vein 2 주 전
Have we hit bottom here ?? Thoughts anyone ?  
👍️0
vein vein 2 주 전
Thanhs Bubba
👍️0
bubbarayjr bubbarayjr 2 주 전
https://ir.stockpr.com/checkpointtx/sec-filings-email/content/0001104659-25-008258/tm255136-1_4seq1.html
👍️0
vein vein 2 주 전
Hey Bubb, I see the cfo received shares , but I don't see the CEO s4??? 
👍️0
bubbarayjr bubbarayjr 2 주 전
CEO just awarded 1.5M shares so I expect to hear partnership/BO news soon
👍️0
vein vein 4 주 전
I guess this medication is worthless 
👍️ 1
vein vein 4 주 전
Ok this is painful 
👍️0
vein vein 1 월 전
This is ridiculous!
👍️0
vein vein 1 월 전
Seriously Zadie 
👍️0
Zadie420 Zadie420 1 월 전
I don't blame you for lightening up of your shares. The behavior of mgt at this stage is not what i thought is going to be. No direction or update from company after approval? You don't do this kind of crap if your company trading on stock mrkt. I am going to watch this for couplie of more days. I think our CEO has a serious issue with communication. Good luck to the company and his employees.
👍️0
vein vein 1 월 전
I may have to lighten up here . I thought the risk would be gone after approval 
👍️0
Zadie420 Zadie420 1 월 전
I know it is very frustrating. Silent from Mgt is appalling. Hanging there.
I am very surprised mgt have not pressure from HFs/institution investors.
👍️0
vein vein 1 월 전
Don't think that is 
👍️0
vein vein 1 월 전
I'm not feeling real comfortable about their execution here Zadie. I dint think there is any partner or buyout interest 
👍️0
vein vein 1 월 전
I fully agree Zadie! We need something positive here . I mean they had a delay and plenty of time to develop something. 
👍️0
Zadie420 Zadie420 1 월 전
I will be ok with $10. But that shows incompetents' of mgt. When you work on a drug, getting approval is one side of the puzzle. commercialization is another. I have not seen any communication from mgt since we have received an approval. This is not good in my opinion.
👍️0
vein vein 1 월 전
I would take 10 zadie! Thanks 
👍️0
Zadie420 Zadie420 1 월 전
Vein,
"J&J to buy neurological drugmaker Intra-Cellular for $14.6 billion. Revenue TTM $613 million."

Note TTM revenue is $613 Mil. Now what do you think our BO should be for CKPT? We expect more revenue based on the # of patients. Even I use 1/10 of BO price of $14.6 Bil. Lets say $1.5 Bil. Then $30/share is reasonable. But you need to be a salesman.
👍️0
vein vein 1 월 전
That would be nice 
👍️0
Zadie420 Zadie420 1 월 전
I think CKPT is a good candid for BO since the mgt failed to deliver any price appreciation after FDA approval. I think even $1B BO i will be happy with it. Someone needs to wake up the mgt.
👍️0
vein vein 1 월 전
That was the biggest trade mistake iof my lifetime Zadie 
👍️0
Zadie420 Zadie420 1 월 전
Yeah. After what happened LWLG. That was a BS. The company performance delayed by another year.
👍️0
vein vein 1 월 전
I can't catch a break Zadie !! Thanks 
👍️0
Zadie420 Zadie420 1 월 전
Vein- I have no idea why this stock is behaving like this. With a minimum OS this should MC of $500M.( at least). I think Market is telling the company that they are not doing their job. In my eyes CEO is responsible for this fiasco.
👍️0
vein vein 1 월 전
Any thoughts on this one Zadie?? 
👍️0
Zadie420 Zadie420 1 월 전
Thanks.
👍️0
vein vein 1 월 전
Honestly Zadie, it was just an article I read in linkdln. It was put out by checkpoint . 
👍️0
Zadie420 Zadie420 1 월 전
What is the competition price? If you have a link to that report i greatly appreciate it. Keep in mind that CKPT got approval based on efficacy not financial cost. At the end survival is more important than the price of medicine. I am very surprised with CEO not addressing this issue.
👍️0
vein vein 1 월 전
Hey Zadie, they were supposed to be able to price it lower than the competition. But now they are saying parity at best . 
👍️0
Zadie420 Zadie420 1 월 전
Do you know what the pricing model was?
👍️0
vein vein 1 월 전
I saw an article that mentions we couldn't deliver on our lower pricing model and we are now seeking a partner ?? Whst the f!! 
👍️0
Zadie420 Zadie420 1 월 전
Yes it is as long as the mgt are silent. This is heaven for traders.
👍️0
vein vein 1 월 전
Man this is brutal 
👍️0
vein vein 1 월 전
Sure would be nice to see some green today !! 
👍️0
vein vein 1 월 전
Thanks Zadie 
👍️0
Zadie420 Zadie420 1 월 전
Check your browser. I can see it in my laptop as well as my phone.
👍️0
vein vein 1 월 전
Can't seem to find it attached Zadie . I see your reply though. 
👍️0
Zadie420 Zadie420 1 월 전
It is post # 272. You should be able to see it.
👍️0
vein vein 1 월 전
Hey swordsman, can you post that YouTube video again ?? Thank you ! 
👍️0
vein vein 1 월 전
Thanks ! 
👍️0
Zadie420 Zadie420 1 월 전
Check swordmsn post. There is a utube clip.
👍️0
vein vein 1 월 전
What clip ?? Mind sharing ?? 
👍️0
Zadie420 Zadie420 1 월 전
Thanks for that clip. Agree. Very interesting and positive.
Does anyone know if we are applying for approval in Europe and UK. Remember these two are two distinct RAs., sine UK exited EU. It appears there are same number pf patient as USA who can use this treatment. This will increase their revenue tremendously.
👍️0
theswordman theswordman 1 월 전
Well its NOT from mngmt. Has ZERO to do with buyouts or info for the flipper crowd

BUT--for the few investors or possible patients or people that have family/friend that might benefit from this treatment

This is VERY POSITIVE !!!!!!!!!!!!!!!!!!!

👍️ 1
vein vein 1 월 전
Man , we need something positive from management here ! 
👍️ 1
Zadie420 Zadie420 2 월 전
Well, the problem is we have no communication from mgt regarding the plan after approval. Are they applying to other RAs for approval? what is expected revenue based first approval and second approval and so on......

You cannot leave these crucial updates untouched and expect the MC increases. I think Mgt and BOD need a wake up calls.
👍️0
vein vein 2 월 전
We might as well not have gotten the drug approved! 
👍️0
Zadie420 Zadie420 2 월 전
Thx for your input
Does anyone knows the projected revenue. Tia
👍️0

최근 히스토리

Delayed Upgrade Clock